跳转至内容
Merck
CN

840008P

Avanti

Lyso PAF (from Heart PC)

Avanti Research - A Croda Brand

别名:

1-alkyl-2-hydroxy-sn-glycero-3-phosphocholine

登录 查看组织和合同定价。

选择尺寸


关于此项目

化学文摘社编号:
MDL number:
UNSPSC Code:
12352211
NACRES:
NA.25
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Lyso PAF (from Heart PC), Avanti Research - A Croda Brand 840008P, powder

SMILES string

O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COCCCCCCCCCCCCCCCC

InChI

1S/C24H52NO6P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-29-22-24(26)23-31-32(27,28)30-21-19-25(2,3)4/h24,26H,5-23H2,1-4H3/t24-/m1/s1

InChI key

VLBPIWYTPAXCFJ-XMMPIXPASA-N

assay

>99% (TLC)

form

powder

packaging

pkg of 1 × 5 mg (840008P-5mg)

manufacturer/tradename

Avanti Research - A Croda Brand 840008P

lipid type

phospholipids
phosphoglycerides

shipped in

dry ice

storage temp.

−20°C

正在寻找类似产品? 访问 产品对比指南

General description

Lyso-platelet activating factor (lyso-PAF) is the alkyl homolog of lysophosphatidylcholine.

Application

Lyso PAF (from Heart PC) (1-alkyl-2-hydroxy-sn-glycero-3-phosphocholine) has been used to study its inhibitory actions on alkyl-PAF-induced death in Swiss albino mice. It may be used as an acyl acceptor in the determination of lysophosphatidic acid (LPA) acyltransferase (LPAAT) activity.

Biochem/physiol Actions

Lyso-platelet activating factor (lyso-PAF) can stimulate inflammation in a murine model of pleurisy. It acts as a stable metabolite and a precursor of PAF. The turnover of lyso-PAF to PAF is expected to induce continued inflammation in target organs or tissues.

Packaging

5 mL Clear Glass Sealed Ampule (840008P-5mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

H Inoue et al.
Life sciences, 52(21), PL227-PL232 (1993-01-01)
The conversion of lyso-platelet activating factor (lyso-PAF) to PAF in cultured paranasal sinus mucosa obtained from normal human subjects was studied. The PAF concentration in the medium was determined after addition of lyso-PAF. PAF became detectable at 10 minutes after
G K Marathe et al.
Journal of lipid research, 42(9), 1430-1437 (2001-08-24)
Lysophosphatidylcholine is an abundant component of plasma and oxidized LDL that displays several biological activities, some of which may occur through the platelet-activating factor (PAF) receptor. We find that commercial lysophosphatidylcholine, its alkyl homolog (lyso-PAF), and PAF all induce inflammation
C Eberhardt et al.
The Journal of biological chemistry, 272(32), 20299-20305 (1997-08-08)
Lysophosphatidic acid (1-acyl-sn-glycero-3-phosphate (LPA)) is a phospholipid with diverse biological activities. The mediator serves as an intermediate in membrane phospholipid metabolism but is also produced in acute settings by activated platelets. LPA is converted to phosphatidic acid, itself a lipid
Vyala Hanumanthareddy Chaithra et al.
Journal of lipid research, 59(11), 2063-2074 (2018-08-25)
Platelet-activating factor (PAF) is a potent inflammatory mediator that exerts its actions via the single PAF receptor (PAF-R). Cells that biosynthesize alkyl-PAF also make abundant amounts of the less potent PAF analogue acyl-PAF, which competes for PAF-R. Both PAF species

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持